Dock-and-Lock (DNL) Complexes for delivery of interference RNA
Described herein are compositions and methods of use of targeted delivery complexes for delivery of siRNA to a disease-associated cell, tissue or pathogen. The targeted delivery complex comprises a targeting molecule, such as an antibody or fragment thereof, conjugated to one or more siRNA carriers. In preferred embodiments the siRNA carrier is a dendrimer or protamine and the targeting molecule is an anti-cancer antibody, such as hRS7. More preferably, the antibody or fragment is rapidly internalized into the target cell to facilitate uptake of the siRNA. Most preferably, the targeted delivery complex is made by the DNL technique. The compositions and methods are of use to treat a variety of disease states, such as cancer, autoimmune disease, immune dysfunction, cardiac disease, neurologic disease, inflammatory disease or infectious disease.
IBC Pharmaceuticals, Inc.
C A A A A C C A C C C C C A A A A C B A A C C
C07K A61P A61P A61K A61P C07K C07K A61P C07K C07K C07K C07K C07K A61P A61K A61P A61P C07K B82Y A61P A61K C07K C07K
additional inventional inventional inventional inventional inventional inventional inventional inventional additional additional additional additional inventional inventional inventional inventional additional inventional inventional inventional inventional additional
David M. Chien-Hsing
Goldenberg Chang